NO339224B1 - Bedrede immunprøvemetoder - Google Patents

Bedrede immunprøvemetoder

Info

Publication number
NO339224B1
NO339224B1 NO20076656A NO20076656A NO339224B1 NO 339224 B1 NO339224 B1 NO 339224B1 NO 20076656 A NO20076656 A NO 20076656A NO 20076656 A NO20076656 A NO 20076656A NO 339224 B1 NO339224 B1 NO 339224B1
Authority
NO
Norway
Prior art keywords
testing methods
improved immune
immune testing
antibody
relats
Prior art date
Application number
NO20076656A
Other languages
English (en)
Other versions
NO20076656L (no
Inventor
John Forsyth Russell Robertson
Tony Barnes
Andrea Murray
Caroline Chapman
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of NO20076656L publication Critical patent/NO20076656L/no
Publication of NO339224B1 publication Critical patent/NO339224B1/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
NO20076656A 2005-05-27 2007-12-27 Bedrede immunprøvemetoder NO339224B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68542205P 2005-05-27 2005-05-27
GB0510943A GB2426581A (en) 2005-05-27 2005-05-27 Immunoassay methods
PCT/GB2006/001944 WO2006126008A2 (en) 2005-05-27 2006-05-26 Improved immunoassay methods

Publications (2)

Publication Number Publication Date
NO20076656L NO20076656L (no) 2008-02-26
NO339224B1 true NO339224B1 (no) 2016-11-21

Family

ID=34834805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076656A NO339224B1 (no) 2005-05-27 2007-12-27 Bedrede immunprøvemetoder

Country Status (19)

Country Link
US (1) US8722339B2 (no)
EP (3) EP1889059B1 (no)
JP (1) JP4876127B2 (no)
KR (1) KR101400986B1 (no)
CN (2) CN101203756B (no)
AT (2) ATE554386T1 (no)
AU (1) AU2006250923B2 (no)
CA (1) CA2609793C (no)
DE (1) DE602006007703D1 (no)
DK (3) DK1889059T3 (no)
ES (3) ES2328171T3 (no)
GB (1) GB2426581A (no)
MX (1) MX2007014815A (no)
NO (1) NO339224B1 (no)
PL (2) PL2073008T3 (no)
PT (2) PT2073008E (no)
RU (1) RU2416095C2 (no)
SI (1) SI2073008T1 (no)
WO (1) WO2006126008A2 (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2424070B (en) * 2002-11-14 2007-06-27 Univ Nottingham Methods for preparing tumour marker proteins
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
PT1889059E (pt) 2005-05-27 2009-10-01 Oncimmune Ltd Métodos de imunoensaio melhorados
WO2007076439A2 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
EP1996716B1 (en) 2006-03-20 2011-05-11 The Regents of the University of California Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
EP2062053B1 (en) * 2006-09-13 2012-12-05 Oncimmune LTD Improved immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
CA2665387A1 (en) * 2006-10-03 2008-04-10 University Of Southern California Grp78 as a predictor of responsiveness to therapeutic agents
ES2530209T3 (es) * 2007-02-23 2015-02-27 Physicians Choice Laboratory Services, Llc Métodos diagnósticos dirigidos a intervención clínica
JP6126773B2 (ja) 2007-09-04 2017-05-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 癌のターゲッティングおよび検出のための高親和性抗前立腺幹細胞抗原(psca)抗体
CN101925364B (zh) 2007-11-27 2014-04-30 不列颠哥伦比亚大学 用于预防和治疗关节炎的14-3-3拮抗剂
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
JP5808538B2 (ja) * 2008-02-21 2015-11-10 アイリス インターナショナル, インコーポレイテッド 前立腺癌治療後の再発に関する早期決定のための方法
JP5433698B2 (ja) 2008-09-19 2014-03-05 リッジビュー ダイアグノスティックス アーベー 固体生物学的物体の分析のための方法
WO2010085548A2 (en) * 2009-01-22 2010-07-29 Li-Cor, Inc. Single molecule proteomics with dynamic probes
WO2010096486A1 (en) 2009-02-17 2010-08-26 Cornell Research Foundation, Inc. Methods and kits for diagnosis of cancer and prediction of therapeutic value
EP2406633B1 (en) * 2009-03-11 2019-01-16 Augurex Life Sciences Corp. Compositions and methods for characterizing arthritic conditions
KR20120098992A (ko) * 2009-06-23 2012-09-06 이벤투스 디아그노스틱스 이스라엘 리미티드 암의 검출을 위한 방법 및 시스템
CN101762700A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法
CA2768398C (en) * 2009-07-24 2020-01-07 Rhode Island Hospital Dendritic cell vaccines for asparaginyl-.beta.-hydroxylase expressing tumors
NZ621655A (en) * 2009-10-26 2015-08-28 Nestec Sa Assays for the detection of anti-tnf drugs and autoantibodies
CA2782333C (en) 2009-12-02 2019-06-04 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
EP2548025A4 (en) 2010-03-17 2013-09-25 Univ Michigan USE OF PHOTOEPITOPES FOR PROFILING AN IMMUNE REACTION
ES2534246T3 (es) 2010-05-12 2015-04-21 Hill's Pet Nutrition, Inc. Métodos para el diagnóstico, control y profilaxis de la inflamación y mitigación de condiciones inflamatorias en los caninos
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
WO2012045279A1 (en) * 2010-10-08 2012-04-12 Shanghai Kexin Biotech Co., Ltd. Moesin fragments associated with immune thrombocytopenia
EA018848B1 (ru) * 2010-10-20 2013-11-29 Вадим Юльевич ШАНИН Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции
CN102125698A (zh) * 2010-11-29 2011-07-20 昆明理工大学 具有正常免疫功能的小鼠移植肿瘤模型的建立方法
JP5837688B2 (ja) 2011-07-01 2015-12-24 イノバ ダイアグノスティックス, インコーポレイテッド 自己免疫疾患についての診断試験の特異性を増大させるための方法
WO2013056377A1 (en) 2011-10-21 2013-04-25 Augurex Life Sciences Corporation Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
CN104428674A (zh) * 2012-04-24 2015-03-18 思研(Sri)国际顾问与咨询公司 前列腺癌和sar-cov的人血清生物标记物
JP2016507748A (ja) * 2013-01-31 2016-03-10 アリゾナ ボード オブ リージェンツ, ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ, アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー 卵巣癌の早期発見のための自己抗体サイン
CN103604923B (zh) * 2013-10-22 2015-05-13 卫生部北京医院 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒
KR102280473B1 (ko) * 2014-02-05 2021-07-22 후지레비오 디아그노스틱스 에이비 악성 신생물 질환의 검출을 위한 조성물 및 방법
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN104356226B (zh) * 2014-11-04 2017-03-29 青岛海兰深生物科技有限公司 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用
NZ739721A (en) 2015-08-07 2019-09-27 Imaginab Inc Antigen binding constructs to target molecules
CN108431605A (zh) * 2015-12-11 2018-08-21 善福德健康 用于监测乳腺癌治疗的试剂和方法
CN106053812B (zh) * 2016-06-29 2017-12-08 厦门生迪生物技术有限公司 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒
JP6334017B1 (ja) * 2017-01-25 2018-05-30 ファナック株式会社 誘導電動機の制御装置
WO2018147960A1 (en) 2017-02-08 2018-08-16 Imaginab, Inc. Extension sequences for diabodies
JP2020524809A (ja) * 2017-06-23 2020-08-20 オンシミューン ジャーマニー ジーエムビーエイチ がんを治療するためのがん免疫
CN111837038A (zh) * 2018-02-01 2020-10-27 思迪亚生物科学公司 用于评估感染持续时间的快速定量分析
WO2022013321A2 (en) 2020-07-14 2022-01-20 Oncimmune Limited Antibody assay
GB2600701A (en) 2020-11-04 2022-05-11 Oncimmune Ltd Antibody assay
CN112345755B (zh) * 2020-09-23 2023-06-16 杭州凯保罗生物科技有限公司 乳腺癌的生物标志物及其应用
GB2622246A (en) 2022-09-08 2024-03-13 Oncimmune Germany Gmbh Antibody assay

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211453A (en) 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
DE3685818T2 (de) 1986-03-10 1993-01-14 Imre Corp Immunkomplextestverfahren.
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
WO1989001153A1 (en) 1987-07-24 1989-02-09 Xoma Corporation Methods for breast cancer detection
US4937185A (en) 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5157020A (en) 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DK9091D0 (da) 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
DE4120412C1 (no) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
DK1024191T3 (da) 1991-12-02 2008-12-08 Medical Res Council Fremstilling af autoantistoffer fremvist på fag-overflader ud fra antistofsegmentbiblioteker
CA2118015A1 (en) 1992-04-14 1993-10-28 Jeffrey R. Marks Method of detecting tumors containing complexes of p53 and hsp70
US5801005A (en) 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
JPH07294530A (ja) * 1994-04-20 1995-11-10 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk 病原体に対する体液中の抗体検出法
CA2148971A1 (en) 1994-05-26 1995-11-27 Izak Bahar Calibrator matrix
JPH10505819A (ja) 1994-06-24 1998-06-09 ヴラディミール ピー. トーチリン 腫瘍の治療及び予防のための自己抗体の使用方法
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US5561049A (en) 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPN568095A0 (en) 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
GB9521544D0 (en) 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
JPH09189702A (ja) 1996-01-09 1997-07-22 Hitachi Chem Co Ltd 抗ムチン抗体の測定法、癌の測定法及び癌診断薬
JP2001517206A (ja) 1996-08-16 2001-10-02 ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
CN1044092C (zh) * 1997-02-26 1999-07-14 上海医科大学 抗原-抗体-重组dna复合型疫苗
WO1998055872A1 (en) 1997-06-03 1998-12-10 Amdl, Inc. Immunoassay for the detection of cancer
DE19805815C1 (de) 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
JP4083855B2 (ja) 1998-02-16 2008-04-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 肺癌予後検査方法
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
CA2349593A1 (en) 1998-11-05 2000-05-11 The Regents Of The University Of Michigan S100 proteins and autoantibodies as serum markers for cancer
US6387639B1 (en) 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US20030138860A1 (en) 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030232399A1 (en) 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
EP1354206A2 (en) 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
CA2451045A1 (en) 2001-06-21 2003-09-04 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2424070B (en) 2002-11-14 2007-06-27 Univ Nottingham Methods for preparing tumour marker proteins
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒
JP2005352771A (ja) 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
WO2007032634A1 (en) 2005-09-12 2007-03-22 Industry Foundation Of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
EP2062053B1 (en) 2006-09-13 2012-12-05 Oncimmune LTD Improved immunoassay methods
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
GB0725239D0 (en) 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Dahlberg T ET AL: "Enzyme-Linked Immunosorbent Assay for Titration of Haemophilus influenza Capsular and O Antigen Antibodies", JOURNAL OF CLINICAL CAPSULAR MICROBIOLOGY, vol. 12, no. 2, 1980, pages 185-192, Dated: 01.01.0001 *
RASMUSSEN N ET AL: "An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA)", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 127, no. 1, 1990, pages 139-145, Dated: 01.01.0001 *
STRAND N ET AL: "Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 193, no. 1, 14 June 1996 (1996.06.14), pages 1-7, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
AU2006250923B2 (en) 2012-06-07
KR20080034851A (ko) 2008-04-22
JP4876127B2 (ja) 2012-02-15
US20080305476A1 (en) 2008-12-11
NO20076656L (no) 2008-02-26
KR101400986B1 (ko) 2014-05-28
PT2275815E (pt) 2014-07-10
WO2006126008A2 (en) 2006-11-30
DE602006007703D1 (de) 2009-08-20
AU2006250923A1 (en) 2006-11-30
CN101203756B (zh) 2016-03-09
EP2275815A2 (en) 2011-01-19
CA2609793A1 (en) 2006-11-30
MX2007014815A (es) 2008-04-11
DK2073008T3 (da) 2012-06-04
PT2073008E (pt) 2012-06-18
ES2328171T3 (es) 2009-11-10
GB0510943D0 (en) 2005-07-06
ATE554386T1 (de) 2012-05-15
RU2007149281A (ru) 2009-07-10
JP2008542703A (ja) 2008-11-27
GB2426581A (en) 2006-11-29
CN101203756A (zh) 2008-06-18
PL2073008T3 (pl) 2012-09-28
EP2073008B1 (en) 2012-04-18
EP1889059A2 (en) 2008-02-20
CA2609793C (en) 2018-05-22
ES2384935T3 (es) 2012-07-16
DK2275815T3 (da) 2014-05-12
ATE436018T1 (de) 2009-07-15
PL1889059T3 (pl) 2009-12-31
CN102749447A (zh) 2012-10-24
DK1889059T3 (da) 2009-11-02
EP1889059B1 (en) 2009-07-08
SI2073008T1 (sl) 2012-08-31
EP2275815B1 (en) 2014-04-02
US8722339B2 (en) 2014-05-13
WO2006126008A3 (en) 2007-03-29
ES2458105T3 (es) 2014-04-29
EP2073008A1 (en) 2009-06-24
CN102749447B (zh) 2015-05-13
RU2416095C2 (ru) 2011-04-10
EP2275815A3 (en) 2011-02-02

Similar Documents

Publication Publication Date Title
NO339224B1 (no) Bedrede immunprøvemetoder
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
BRPI0509419A (pt) método de ensaio imunossorvente ligado por enzimas, anticorpos, hibridoma e kit de imunoensaio
ATE438853T1 (de) Diagnostische testvorrichtung
DE50210025D1 (de) Schnelltest für biologische substanzen mittels ftir
EP1930445A4 (en) KIT AND METHOD FOR DETECTING UROTHELIAL CANCER
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
DE602006014581D1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
NZ592819A (en) Thyroid analyte detection and measurement
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
CY1113013T1 (el) Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
EP2444812A3 (en) Improved immunoassay methods
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
CY1115323T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
AR066491A1 (es) Equipo de enzimoinmunoensayo ( elisa) para el diagnostico de leptospirosis humana
CY1113688T1 (el) Βελτιωμενες μεθοδοι ανοσοπροσδιορισμου
TH106073A (th) การทดสอบวิเคราะห์ elisa สำหรับตรวจหา vegf

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees